Embedded Files
IMARC Group’s report titled “Nutrigenomics Market Report by Product (Reagents and Kits, Services), Sample Type (Saliva, Buccal Swab, Blood, and Others), Application (Cardiovascular Diseases, Obesity, Cancer Research, and Others), End User (Dieticians, Sport Clinics, Corporate Programs, and Others), and Region 2024–2032”. The global nutrigenomics market size reached US$ 1,212.6 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 3,049.7 Million by 2032, exhibiting a growth rate (CAGR) of 10.47% during 2024–2032.
Grab a sample PDF of this report: https://www.imarcgroup.com/nutrigenomics-market/requestsample
Factors Affecting the Growth of the Nutrigenomics Industry:
Rising Prevalence of Chronic Diseases:
Nutrigenomics enables a personalized approach to disease prevention by identifying genetic predispositions of individuals to chronic diseases, such as obesity, diabetes, cardiovascular diseases (CVDs), and certain types of cancer. Moreover, nutrigenomics allows for the development of targeted intervention strategies based on genetic profiles. Individuals at higher genetic risk for specific chronic diseases can receive personalized dietary guidance aimed at mitigating risk factors and promoting better health outcomes. This targeted approach is more effective than generic dietary recommendations and can help in preventing or delaying the onset of chronic diseases.
Technological Advancements:
Innovations in genomic sequencing are significantly reducing the cost and time required for DNA analysis. Next-generation sequencing (NGS) and other high-throughput sequencing technologies enable rapid and cost-effective analysis of genetic variations associated with nutrition and health. This accessibility is facilitating the widespread adoption of nutrigenomics testing and personalized nutrition services. Furthermore, advancements in bioinformatics and data analysis tools are improving the ability to interpret complex genomic data. These tools enable researchers and healthcare providers to analyze large-scale genomic datasets, identify relevant genetic variations, and generate actionable insights related to nutrition and health.
Growing Demand for Personalized Nutrition:
Increasing awareness among the masses about the importance of nutrition in maintaining overall health and well-being is leading people to seek personalized dietary solutions. Individuals are becoming more proactive in managing their health and are interested in personalized approaches that cater as per their unique nutritional needs and goals. In addition, personalized nutrition recognizes that individuals have diverse genetic backgrounds, lifestyles, and health conditions that influence their nutritional requirements. Nutrigenomics allows for the customization of dietary recommendations based on individual genetic profiles, enabling more precise and effective interventions tailored as per the specific needs and goals of people.
Leading Companies Operating in the Global Nutrigenomics Industry:
BASF SE
Cell-Logic
Cura Integrative Medicine
Danone S.A, Fagron
Genova Diagnostics
Holistic Health International
Koninklijke DSM N.V.
Metagenics Inc.
Nutrigenomix Inc.
Xcode Life.
Nutrigenomics Market Report Segmentation:
By Product:
Reagents and Kits
Services
Reagents and kits represent the largest segment due to their pivotal role in facilitating research and analysis in this field.
By Sample Type:
Saliva
Buccal Swab
Blood
Others
Based on the sample type, the market has been classified into saliva, buccal swab, blood, and others.
By Application:
Cardiovascular Diseases
Obesity
Cancer Research
Others
Obesity holds the biggest market share owing to its significant prevalence and the growing awareness about personalized nutrition potential in managing weight-related issues.
By End User:
Dieticians
Sport Clinics
Corporate Programs
Others
On the basis of the end user, the market has been divided into dieticians, sport clinics, corporate programs, and others.
Regional Insights:
North America (the United States and Canada)
Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others)
Europe (Germany, France, the United Kingdom, Italy, Spain, and others)
Latin America (Brazil, Mexico, and others); the Middle East; and Africa.
North America enjoys the leading position in the nutrigenomics market on account of a significant investment in research and development (R&D) activities, particularly in the fields of genetics, nutrition, and healthcare.
Global Nutrigenomics Market Trends:
Miniaturized and portable devices for genetic testing and biomarker analysis are expanding access to nutrigenomics services outside traditional laboratory settings. Point-of-care (POC) testing devices enable rapid and convenient genetic profiling, empowering people to obtain personalized nutrition advice in real time. These devices facilitate personalized dietary interventions at the point of need, promoting better adherence to nutrition recommendations and improving health outcomes.
In addition, the growing integration of artificial intelligence (AI) and machine learning (ML) algorithms into nutrigenomics platforms is enhancing the interpretation of genetic data and the development of personalized dietary recommendations, thereby positively influencing the market.
Note: If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
Other Related Reports By IMARC Group
Earbuds Market: https://www.imarcgroup.com/earbuds-market
Automotive HMI Market: https://www.imarcgroup.com/automotive-hmi-market
AI in Agriculture Market: https://www.imarcgroup.com/ai-in-agriculture-market
Insect Growth Regulators Market: https://www.imarcgroup.com/insect-growth-regulators-market
Veterinary Vaccines Market: https://www.imarcgroup.com/veterinary-vaccines-market
Immunotherapy Drugs Market: https://www.imarcgroup.com/immunotherapy-drugs-market
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC Group’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact US
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
United States: +1–631–791–1145 | United Kingdom: +44–753–713–2163
Page updated
Google Sites
Report abuse